Cargando…
Polyhydroxyalkanoate Decelerates the Release of Paclitaxel from Poly(lactic-co-glycolic acid) Nanoparticles
Biodegradable nanoparticles (NPs) are preferred as drug carriers because of their effectiveness in encapsulating drugs, ability to control drug release, and low cytotoxicity. Although poly(lactide co-glycolide) (PLGA)-based NPs have been used for controlled release strategies, they have some disadva...
Autores principales: | Lee, Si Yeong, Kim, So Yun, Ku, Sook Hee, Park, Eun Ji, Jang, Dong-Jin, Kim, Sung Tae, Kim, Seong-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416746/ https://www.ncbi.nlm.nih.gov/pubmed/36015244 http://dx.doi.org/10.3390/pharmaceutics14081618 |
Ejemplares similares
-
Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma
por: Ganipineni, Lakshmi Pallavi, et al.
Publicado: (2018) -
Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer
por: Cabeza, Laura, et al.
Publicado: (2022) -
Paclitaxel-incorporated nanoparticles using block copolymers composed of poly(ethylene glycol)/poly(3-hydroxyoctanoate)
por: Kim, Hyun Yul, et al.
Publicado: (2014) -
Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy
por: Wang, Xiaoling, et al.
Publicado: (2018) -
Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells
por: Sharma, Nikita, et al.
Publicado: (2020)